Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Patient Case Study: Elderly
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Patient Case Study: Obesity
Optimizing AAV Outcomes: Maintenance Therapies
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Alexander T. Cohen, MD, MBBS
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Andreas Kronbichler, MD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Patient Case Study: Cancer-Associated Thrombosis
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
John Russell, MD
Noel Dasgupta, MD, FACC
Sami Khella, MD
No benefit of routine spironolactone post-MI
Sanjit Jolly, MD
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Subodh Verma, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.